Navigation Links
Nexavar Significantly Improved Overall Survival in Phase 3 Asia-Pacific Liver Cancer Trial
Date:8/26/2007

//www.nexavar.com" target="_new">http://www.nexavar.com or call 1.866.NEXAVAR (1.866.639.2827).

About Onyx Pharmaceuticals, Inc.

Onyx Pharmaceuticals, Inc. is a biopharmaceutical company developing innovative therapies that target the molecular mechanisms that cause cancer. The company is developing Nexavar(R), a small molecule drug, with Bayer Healthcare Pharmaceuticals. For more information about Onyx's pipeline and activities, visit the company's web site at: http://www.onyx-pharm.com.

About Bayer HealthCare Pharmaceuticals

Bayer HealthCare Pharmaceuticals Inc. is the U.S.-based pharmaceuticals unit of Bayer HealthCare LLC, a division of Bayer AG. Its research and business activities are focused on the following areas: Diagnostic Imaging, Hematology/Cardiology, Oncology, Primary Care, Specialized Therapeutics and Women's Healthcare. The company's aim is to discover and manufacture products that will improve human health worldwide by diagnosing, preventing and treating diseases.

Forward Looking Statements

This news release contains forward-looking statements based on current assumptions and forecasts made by Bayer Group management. Various known and unknown risks, uncertainties and other factors could lead to material differences between the actual future results, financial situation, development or performance of the company and the estimates given here. These factors include those discussed in Bayer's public reports filed with the Frankfurt Stock Exchange and with the U.S. Securities and Exchange Commission (including its Form 20-F). Bayer assumes no liability whatsoever to update these forward-looking statements or to conform them to future events or developments.

This news release also contains "forward-looking statements" of Onyx within the meaning of the federal securities laws. These forward-looking statements include without limitation, statements regarding
'/>"/>

SOURCE Bayer HealthCare Pharmaceuticals Inc.; Onyx
Pharmaceuticals, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Nexavar Significantly Extends Overall Survival by 44% in Liver Cancer Patients
2. Review of Nexavar Data Presented at ASCO 2007- Investor Conference Call on June 4, 2007
3. Liraglutide provides significantly better glucose control than insulin glargine in phase 3 study
4. Arterial Plaque Significantly Reduced in Women Age 50-59 Taking Hormones, Says New Analysis of Womens Health Initiative Data
5. Prexige Study Shows Significantly Less Impact on Blood Pressure Than Ibuprofen in Osteoarthritis Patients with Controlled Hypertension
6. Lumiracoxib Study Showed Significantly Less Impact on Blood Pressure Than Ibuprofen in Osteoarthritis Patients with Controlled Hypertension
7. Actemra (tocilizumab) Significantly Improves Symptoms of Rheumatoid Arthritis Compared to a Current Standard of Care
8. Next Safety, Inc.s Innovative Drug Delivery System Will Replace Cigarettes and Significantly Advance Pulmonary Medication Delivery
9. Ivivis PEMF Technology Significantly Improves Neuron Survival in Parkinsons Disease Model, Study Finds
10. Mercks Investigational Migraine Treatment MK-0974 Significantly Improved Migraine Pain on Several Efficacy Measures in a Phase II Study
11. The Eloxatin-Based Regimen (FOLFOX4) Significantly Improved Progression Free Survival When Given Before and After Surgery in Patients With Resectable Liver Metastases From Colorectal Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/27/2015)... Israele, February 27, 2015 ... sviluppo dell,innovativo sistema di monitoraggio dell,infarto congestizio (CHF ... sull,uomo-     ... di nuovo sistema per il monitoraggio cardiaco destinato ... annunciato oggi di aver concluso una raccolta di ...
(Date:2/27/2015)... Isis Pharmaceuticals, Inc. (Nasdaq: ISIS ... forma net operating loss (NOL) guidance and its cash ...  Isis, significantly improved financial results were due in large ... the Company received from its partners.  Isis, pro forma ... 60% improvement over its 2013 NOL of $40.2 million. ...
(Date:2/27/2015)... N.J. , Feb. 27, 2015 An ... has helped cut the rate of infection with a ... 40 percent. Clostridium difficile, or C.diff, is ... to life-threatening inflammation of the colon. A recent article ... of Clostridium difficile Infection in the United ...
Breaking Medicine Technology:Vectorious Medical Technologies completa una raccolta di 5 milioni di dollari 2Isis Reports Financial Results and Highlights for 2014 2Isis Reports Financial Results and Highlights for 2014 3Isis Reports Financial Results and Highlights for 2014 4Isis Reports Financial Results and Highlights for 2014 5Isis Reports Financial Results and Highlights for 2014 6Isis Reports Financial Results and Highlights for 2014 7Isis Reports Financial Results and Highlights for 2014 8Isis Reports Financial Results and Highlights for 2014 9Isis Reports Financial Results and Highlights for 2014 10Isis Reports Financial Results and Highlights for 2014 11Isis Reports Financial Results and Highlights for 2014 12Isis Reports Financial Results and Highlights for 2014 13Isis Reports Financial Results and Highlights for 2014 14Isis Reports Financial Results and Highlights for 2014 15Isis Reports Financial Results and Highlights for 2014 16Isis Reports Financial Results and Highlights for 2014 17Curb Overuse Of Antibiotics To Reduce Drug-Resistant Superbug 2Curb Overuse Of Antibiotics To Reduce Drug-Resistant Superbug 3
... , SOUTH SAN FRANCISCO, Calif. , ... Bulletin Board: VXGN), announced today that Institutional Shareholder Services/Risk Metrics ... leading independent proxy advisory firms, recommend that VaxGen stockholders vote ... and "FOR" the Proposal to adjourn the VaxGen special meeting, ...
... , NEW YORK , Jan. 25 ... granted a license by the Virginia Department of Health to ... Virginia as a Private Review Agent (PRA). This license ... for commercial, Medicare, and Medicaid products offered by health plans, ...
Cached Medicine Technology:ISS/Risk Metrics Group and Glass Lewis Recommend VaxGen Stockholders Vote 'For' Proposed Merger With OXiGENE 2ISS/Risk Metrics Group and Glass Lewis Recommend VaxGen Stockholders Vote 'For' Proposed Merger With OXiGENE 3ISS/Risk Metrics Group and Glass Lewis Recommend VaxGen Stockholders Vote 'For' Proposed Merger With OXiGENE 4ISS/Risk Metrics Group and Glass Lewis Recommend VaxGen Stockholders Vote 'For' Proposed Merger With OXiGENE 5Care to Care Licensed to Manage High-cost Radiology in Virginia 2Care to Care Licensed to Manage High-cost Radiology in Virginia 3
(Date:2/27/2015)... NY (PRWEB) February 27, 2015 The ... http://www.lipitorlawsuitcenter.com/ ) that allege use of the statin medication ... diabetes has issued a new order pertaining discovery in ... trials, Bernstein Liebhard LLP comments. The Order, which was ... Carolina, on February 25th, directs the parties to schedule ...
(Date:2/27/2015)... Chicago, IL (PRWEB) February 27, 2015 ... at Lutheran General Hospital on June 25, 2013 and ... into her stomach through her mouth. Because the ... became infected with the antibiotic-resistant “superbug” carbapenem-resistant Enterobacteriaceae (CRE). ... the Circuit Court of Cook County on behalf of ...
(Date:2/27/2015)... (PRWEB) February 27, 2015 Adding ... devices and pharmaceuticals, Benedict Advertising & Marketing has ... newest client. The company’s patented NITROUSEAL® N20 closed ... no-stress method of sedation. , Sedation Systems, ... comfort to a new level, though it focuses ...
(Date:2/27/2015)... (PRWEB) February 27, 2015 The Dawn Greene ... Mary Manning Walsh Home (MMW) on the Upper East Side, ... Archbishop of New York, His Eminence Timothy Michael Cardinal Dolan. ... Hospital Board of Directors and a member of the ArchCare ... Sr. Sean William O’Brien, O.Carm, executive director of MMW, and ...
(Date:2/27/2015)... Florida Hospital North Pinellas is being recognized ... Plus hospital. In order to receive the award, Florida ... all Get With The Guidelines - Stroke Quality Achievement ... achieved 75-percent or higher compliance with six of 10 ... are reporting initiatives to measure quality of care. ...
Breaking Medicine News(10 mins):Health News:Federal Lipitor Litigation Issues New Order Pertaining to Discovery in Bellwether Cases, Bernstein Liebhard LLP Comments 2Health News:Federal Lipitor Litigation Issues New Order Pertaining to Discovery in Bellwether Cases, Bernstein Liebhard LLP Comments 3Health News:Lawsuit Alleges Blame on Scope Manufacturer for "Superbug" Outbreak 2Health News:Benedict Advertising & Marketing Signs Sedation Systems 2Health News:The Dawn Greene Hospice Is Officially Dedicated 2Health News:The Dawn Greene Hospice Is Officially Dedicated 3Health News:Florida Hospital North Pinellas Receives Get With The Guidelines - Stroke Gold Plus Quality Achievement Award 2
... efforts to promote Kerala as an ideal destination for medical tourism, ... US, Britain, Dubai, Muscat, Kuwait, Sri Lanka and the Maldives. ... to be systematic and we have asked the CII (Confederation of ... and when we announce it shortly we would become the first ...
... may have shorter life spans than those who sleep less, says ... ,Based on a nationwide survey of 1.1 million adults, the study ... that those who slept eight hours a night were 12 percent ... 6 1/2 to 7 1/2 hours, reported the online edition of ...
... Army officer has become the first person to donate his ... ,Major S.K. Singh of the Regiment of Artillery agreed to ... brain dead at the premier Army Hospital (Research & Referral) ... ,The elder Singh was suffering from diabetes ...
... Scientists at the University of Oxford have discovered a unique ... The system is a form of RNA, a chemical found ... mystery; scientists are presently exploring this area and its role ... plays an important and direct role in the synthesis of ...
... attacks healthy young people and can kill within 24 hours.// ... to find a cure for the virulent disease, PVL-MRSA, that is ... for two deaths in Britain, experts fear we are in the ... death toll if the superbug took hold in hospitals. ...
... shown that a drug commonly used to lower blood ... Marfan syndrome and also prevents muscle degeneration in mice ... reported online this week at Nature Medicine. ... M.D., discovered that treating Marfan mice with losartan (Cozaar) ...
Cached Medicine News:Health News:Role of RNA in Checking the Development of Tumors 2Health News:Common BP Drug Treats Muscular Dystrophy 2Health News:Common BP Drug Treats Muscular Dystrophy 3
... InBios' West Nile Detect™ IgM Capture ELISA ... IgM antibodies to WNV recombinant antigens (WNRA) ... clinical laboratory diagnosis of West Nile virus ... with encephalitis/meningitis. Positive results must be confirmed ...
... for dilation of urethral strictures ... the bladder. The flare at ... catheter fits a standard irrigation ... threaded to attach to a ...
Used to dilate the male or female urethra to treat stricture disease. Supplied sterile in peel-open packages. Intended for one-time use....
The removable inflation adapter allows the ureteroscope to be removed after the catheter is in place. Supplied sterile in peel-open packages. Intended for one-time use....
Medicine Products: